Protara Therapeutics Inc (TARA)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
| CEO: | Jesse Shefferman |
| Employees: | 30 |
| Web site: | protaratx.com |
|
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
646-844-0337
| |
| Date | Ratio |
|---|---|
| 2020-01-10 | 1:40 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Protara Therapeutics, Inc. engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the. treatment of lymphatic malformations. It also develops intravenous choline chloride, an. investigational phospholipid substrate replacement therapy.
Please log in first to see chart